ACIU Cash Ratio from 2010 to 2024

ACIU Stock  USD 3.38  0.09  2.74%   
AC Immune Cash Ratio yearly trend continues to be comparatively stable with very little volatility. Cash Ratio is likely to outpace its year average in 2024. From the period from 2010 to 2024, AC Immune Cash Ratio quarterly data regression had r-value of  0.37 and coefficient of variation of  76.66. View All Fundamentals
 
Cash Ratio  
First Reported
2010-12-31
Previous Quarter
5.78182086
Current Value
9
Quarterly Volatility
5.27488305
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AC Immune financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AC Immune's main balance sheet or income statement drivers, such as Interest Expense of 167.2 K, Selling General Administrative of 8.3 M or Total Revenue of 20 M, as well as many indicators such as Price To Sales Ratio of 38.71, Dividend Yield of 0.0 or PTB Ratio of 2.11. ACIU financial statements analysis is a perfect complement when working with AC Immune Valuation or Volatility modules.
  
Check out the analysis of AC Immune Correlation against competitors.
For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.

Latest AC Immune's Cash Ratio Growth Pattern

Below is the plot of the Cash Ratio of AC Immune over the last few years. It is AC Immune's Cash Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AC Immune's overall financial position and show how it may be relating to other accounts over time.
Cash Ratio10 Years Trend
Slightly volatile
   Cash Ratio   
       Timeline  

ACIU Cash Ratio Regression Statistics

Arithmetic Mean6.88
Geometric Mean4.52
Coefficient Of Variation76.66
Mean Deviation4.79
Median5.78
Standard Deviation5.27
Sample Variance27.82
Range14.5925
R-Value0.37
Mean Square Error25.85
R-Squared0.14
Significance0.17
Slope0.44
Total Sum of Squares389.54

ACIU Cash Ratio History

2024 9.0
2023 5.78
2022 2.75
2021 4.11
2020 11.48
2019 11.06
2018 11.96

About AC Immune Financial Statements

AC Immune shareholders use historical fundamental indicators, such as Cash Ratio, to determine how well the company is positioned to perform in the future. Although AC Immune investors may analyze each financial statement separately, they are all interrelated. The changes in AC Immune's assets and liabilities, for example, are also reflected in the revenues and expenses on on AC Immune's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cash Ratio 5.78  9.00 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for ACIU Stock Analysis

When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.